Nolph K D, Lindblad A S, Novak J W
Clinical Coordinating Center, National Institutes of Health Continuous Ambulatory Peritoneal Dialysis Registry.
N Engl J Med. 1988 Jun 16;318(24):1595-600. doi: 10.1056/NEJM198806163182407.
As a long-term dialysis therapy, CAPD has attractive features for use in children (in whom access to the circulation and immobility are often problems), adults in whom blood access is difficult, patients with diabetes, patients prone to hypotension, and patients seeking independence from a machine or medical facility. CAPD and related procedures are still evolving and improving. Efforts to reduce the rates of peritonitis are ongoing and should decrease the rates of treatment dropout and increase the use of this alternative method of dialysis. Continued research toward improvements in catheter configuration and connection devices and the tailoring of technique to meet the particular needs of patients have made peritoneal dialysis an acceptable replacement therapy in patients with end-stage renal disease. Neither peritoneal dialysis nor hemodialysis is the superior long-term dialysis therapy for all patients; the choice depends on numerous medical, social, geographic, and life-style considerations.
作为一种长期透析疗法，持续性非卧床腹膜透析（CAPD）对于儿童（他们常常存在血管通路和活动受限问题）、建立血液通路困难的成年人、糖尿病患者、易发生低血压的患者以及寻求摆脱机器或医疗机构束缚以实现自理的患者而言，具有吸引人的特性。CAPD及相关操作仍在不断发展和改进。降低腹膜炎发生率的努力一直在进行，这有望降低治疗中断率，并增加这种替代透析方法的使用。针对改进导管结构和连接装置以及根据患者特殊需求调整技术的持续研究，已使腹膜透析成为终末期肾病患者可接受的替代治疗方法。对于所有患者而言，腹膜透析和血液透析都不是 superior 的长期透析疗法；选择取决于众多医学、社会、地理和生活方式等方面的因素。 （注：原文中“superior”此处翻译为“更优的、更好的”等意思更合适，但按照要求保留英文未翻译完整。）
